171 related articles for article (PubMed ID: 38182917)
1. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study.
Besi E; Pitros P
Oral Maxillofac Surg; 2024 Jun; 28(2):785-793. PubMed ID: 38182917
[TBL] [Abstract][Full Text] [Related]
2. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
3. Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study.
Jamalpour MR; Shahabi S; Baghestani M; Shokri A; Jamshidi S; Khazaei S
BMC Oral Health; 2022 Jun; 22(1):241. PubMed ID: 35717177
[TBL] [Abstract][Full Text] [Related]
4. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ).
Miranda M; Gianfreda F; Raffone C; Antonacci D; Pistilli V; Bollero P
Biomed Res Int; 2021; 2021():4948139. PubMed ID: 34095295
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study.
Parise GK; Costa BN; Nogueira ML; Sassi LM; Schussel JL
Oral Maxillofac Surg; 2023 Sep; 27(3):507-512. PubMed ID: 35739366
[TBL] [Abstract][Full Text] [Related]
6. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
[TBL] [Abstract][Full Text] [Related]
7. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
8. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
[TBL] [Abstract][Full Text] [Related]
9. Use of Leukocyte-rich and Platelet-rich Fibrin (L-PRF) Adjunct to Surgical Debridement in the Treatment of Stage 2 and 3 Medication-Related Osteonecrosis of the Jaw.
Yalcin-Ülker GM; Duygu G; Tanan G; Cakir M; Meral DG
J Craniofac Surg; 2023 May; 34(3):1039-1044. PubMed ID: 36627754
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the jaw induced by bisphosphonates therapy in bone metastases patient: Case report and literature review.
Hao L; Tian Z; Li S; Yan K; Xue Y
Oral Oncol; 2022 May; 128():105852. PubMed ID: 35439709
[TBL] [Abstract][Full Text] [Related]
11. Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study.
Asaka T; Ohga N; Yamazaki Y; Sato J; Satoh C; Kitagawa Y
Clin Oral Investig; 2017 Sep; 21(7):2165-2172. PubMed ID: 27837344
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of advanced-platelet rich fibrin (A-PRF) and injectable-platelet rich fibrin (i-PRF) in the management of a massive medication-related osteonecrosis of the jaw (MRONJ): A 5-years follow-up case report.
Giudice A; Antonelli A; Muraca D; Fortunato L
Indian J Dent Res; 2020; 31(5):813-818. PubMed ID: 33433526
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
15. Prevention and management of drug-induced osteonecrosis of the jaws using platelet-rich fibrin: A clinical feasibility study.
Alrmali A; Saleh MHA; Kurdi SMS; Sabri H; Meghil MM; Wang HL
Clin Exp Dent Res; 2023 Oct; 9(5):791-798. PubMed ID: 37605488
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study.
Cuozzo A; Iorio-Siciliano V; Vaia E; Mauriello L; Blasi A; Ramaglia L
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):616-621. PubMed ID: 35609780
[TBL] [Abstract][Full Text] [Related]
17. Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin.
Özalp Ö; Yıldırımyan N; Öztürk C; Kocabalkan B; Şimşek Kaya G; Sindel A; Altay MA
BMC Oral Health; 2021 Dec; 21(1):613. PubMed ID: 34852823
[TBL] [Abstract][Full Text] [Related]
18. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients.
Coropciuc R; Coopman R; Garip M; Gielen E; Politis C; Van den Wyngaert T; Beuselinck B
Bone; 2023 May; 170():116722. PubMed ID: 36858337
[TBL] [Abstract][Full Text] [Related]
19. A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab.
Bracchi P; Zecca E; Brunelli C; Miceli R; Tinè G; Maniezzo M; Lo Dico S; Caputo M; Shkodra M; Caraceni AT
Cancer Med; 2023 Sep; 12(17):18317-18326. PubMed ID: 37559413
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
